Zhao Hui Chen Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhao Hui Chen Zhou has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
Amaya Hilario
Department of Radiology, Neurorradiology Section, Hospital Universitario 12 De Octubre, Madrid, Spain
8 shared publicationsElena Salvador Álvarez
Department of Radiology, Neurorradiology Section, Hospital Universitario 12 De Octubre, Madrid, Spain
7 shared publicationsAna Martínez de Aragón
Department of Radiology, Neurorradiology Section, Hospital Universitario 12 De Octubre, Madrid, Spain
6 shared publicationsCarmen Lechuga
Department of Radiology, Neurorradiology Section, Hospital Universitario 12 De Octubre, Madrid, Spain
6 shared publicationsAna Ramos
Hospital Universitario 12 de Octubre
5 shared publicationsAna Ramos González
Neurorradiology Section, Department of Radiology Hospital Universitario 12 de Octubre Madrid Spain
5 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by Springer Nature in Research Square
A multicentre longitudinal brain metastasis imaging dataset with lesion segmentations and clinical data
Brain metastases exhibit substantial variability in lesion burden, morphology and treatment response. Longitudinal imaging linked to lesion annotations and clinical histories can support quantitative studies of this heterogeneity. We describe a multicentre dataset from seven Spanish hospitals comprising 443 patients diagnosed between 2007 and 2022, with follow-up imaging for 216 patients. The collection contains 2842 magnetic resonance image, including 1092 three dimensional (3D) contrast-enhanced T1-weighted, 833 T2-weighted and 917 FLAIR (fluid-attenuated inversion recovery) images. Semiautomatic 3D-segmentation with expert review provides annotations for 1291 unique lesions represented by 2303 lesion observations across imaging time points. Separate labels identify contrast-enhancing and non-enhancing or necrotic tumour components, and lesion identifiers are maintained during follow-up. Accompanying records describe primary tumour characteristics, treatments, imaging dates and clinical outcomes, together with acquisition metadata and 107 morphological and radiomic features. The dataset supports research on lesion detection and segmentation, longitudinal response assessment, imaging biomarkers and mathematical models of brain metastasis growth and treatment response.
- 9 November 2026
- Published by Springer Nature in Research Square
Open AccessA multicentre longitudinal brain metastasis imaging dataset with lesion segmentations and clinical data
Brain metastases exhibit substantial variability in lesion burden, morphology and treatment response. Longitudinal imaging linked to lesion annotations and clinical histories can support quantitative studies of this heterogeneity. We describe a multicentre dataset from seven Spanish hospitals comprising 443 patients diagnosed between 2007 and 2022, with follow-up imaging for 216 patients. The collection contains 2842 magnetic resonance image, including 1092 three dimensional (3D) contrast-enhanced T1-weighted, 833 T2-weighted and 917 FLAIR (fluid-attenuated inversion recovery) images. Semiautomatic 3D-segmentation with expert review provides annotations for 1291 unique lesions represented by 2303 lesion observations across imaging time points. Separate labels identify contrast-enhancing and non-enhancing or necrotic tumour components, and lesion identifiers are maintained during follow-up. Accompanying records describe primary tumour characteristics, treatments, imaging dates and clinical outcomes, together with acquisition metadata and 107 morphological and radiomic features. The dataset supports research on lesion detection and segmentation, longitudinal response assessment, imaging biomarkers and mathematical models of brain metastasis growth and treatment response.
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 8 (6)
Nonenhancing Leptomeningeal Metastasis: The Bloomy Rind Sign
- 1 November 2026
- Published by Radiological Society of North America (RSNA) in Radiology: Imaging Cancer
- Vol. 8 (6)
Nonenhancing Leptomeningeal Metastasis: The Bloomy Rind Sign
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 22, 1-16
Beyond Brain Parenchyma: A Pictorial Review of Non-Parenchymal and Extracranial Metastases on Cranial MRI
Brain MRI is the primary imaging technique used to detect, stage, and monitor intracranial metastatic disease. While parenchymal metastases are easily identifiable, metastatic involvement beyond the brain parenchyma is frequently subtle and underreported, despite representing a significant proportion of metastatic findings identified during cranial examinations. Failure to identify these metastases, or identification at a late stage, can lead to incomplete staging, inappropriate treatment selection, and delays in initiating targeted therapies. This pictorial review presents a systematic, compartment-based approach to non-parenchymal intracranial and extracranial metastases encountered on cranial MRI scans. The review covers metastatic involvement of the calvaria and skull base, leptomeninges, dura mater, ventricular system and choroid plexus, pituitary–hypothalamic axis, pineal gland, orbit, parotid gland, head and neck musculature, cutaneous and subcutaneous tissues, and upper cervical spinal cord. For each compartment, we summarize the most relevant clinical presentations, routes of dissemination, characteristic MRI patterns, major differential diagnoses, and practical diagnostic clues. Particular emphasis is placed on findings that may improve recognition in routine practice, including marrow replacement, leptomeningeal and cranial nerve enhancement, dural-based masses, infundibular involvement, rapidly growing pineal lesions, intraventricular enhancing masses, orbital infiltration, soft-tissue nodules, and intramedullary spinal cord lesions with extensive edema. A structured review of compartments beyond the brain parenchyma may improve detection and diagnostic confidence in oncologic cranial MRI. Awareness of common mimics and integration with oncologic history and interval changes are essential to avoid diagnostic pitfalls.
- 29 September 2026
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 22, 1-16
Beyond Brain Parenchyma: A Pictorial Review of Non-Parenchymal and Extracranial Metastases on Cranial MRI
Brain MRI is the primary imaging technique used to detect, stage, and monitor intracranial metastatic disease. While parenchymal metastases are easily identifiable, metastatic involvement beyond the brain parenchyma is frequently subtle and underreported, despite representing a significant proportion of metastatic findings identified during cranial examinations. Failure to identify these metastases, or identification at a late stage, can lead to incomplete staging, inappropriate treatment selection, and delays in initiating targeted therapies. This pictorial review presents a systematic, compartment-based approach to non-parenchymal intracranial and extracranial metastases encountered on cranial MRI scans. The review covers metastatic involvement of the calvaria and skull base, leptomeninges, dura mater, ventricular system and choroid plexus, pituitary–hypothalamic axis, pineal gland, orbit, parotid gland, head and neck musculature, cutaneous and subcutaneous tissues, and upper cervical spinal cord. For each compartment, we summarize the most relevant clinical presentations, routes of dissemination, characteristic MRI patterns, major differential diagnoses, and practical diagnostic clues. Particular emphasis is placed on findings that may improve recognition in routine practice, including marrow replacement, leptomeningeal and cranial nerve enhancement, dural-based masses, infundibular involvement, rapidly growing pineal lesions, intraventricular enhancing masses, orbital infiltration, soft-tissue nodules, and intramedullary spinal cord lesions with extensive edema. A structured review of compartments beyond the brain parenchyma may improve detection and diagnostic confidence in oncologic cranial MRI. Awareness of common mimics and integration with oncologic history and interval changes are essential to avoid diagnostic pitfalls.
- 20 August 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (9) , 1685-1694
Influence of metastases composition on the conspicuity of melanoma brain metastases: a comparative study of post-contrast 3D T1WI GRE versus 3D T1WI TSE black blood
- 20 August 2026
- Published by Springer Nature in La radiologia medica
- Vol. 131 (9) , 1685-1694
Influence of metastases composition on the conspicuity of melanoma brain metastases: a comparative study of post-contrast 3D T1WI GRE versus 3D T1WI TSE black blood
- 26 February 2026
- Published by Elsevier in Radiología (English Edition)
- Vol. 68 (2) , 501805
Renewal and leadership: How young members contribute to scientific societies
- 26 February 2026
- Published by Elsevier in Radiología (English Edition)
- Vol. 68 (2) , 501805
Renewal and leadership: How young members contribute to scientific societies
- Open Access
- 12 December 2025
- Published by Wiley in iRADIOLOGY
- Vol. 3 (6) , 490-492
Central‐Variant Posterior Reversible Encephalopathy Syndrome With Brainstem Involvement
- 12 December 2025
- Published by Wiley in iRADIOLOGY
- Vol. 3 (6) , 490-492
Open AccessCentral‐Variant Posterior Reversible Encephalopathy Syndrome With Brainstem Involvement
- 29 October 2025
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 176 (1) , 1-10
Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery
Purpose To compare the diagnostic performance of relative cerebral blood volume (rCBV) and percentage of signal recovery (PSR), both derived from dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI), in distinguishing tumor progression from radiation necrosis in brain metastases that have been treated with stereotactic radiosurgery (SRS). Methods This retrospective, single-centre study analysed 96 brain metastases with post-radiotherapy increase in contrast enhancement. The lesions were classified as tumor progression (n = 46) or radiation necrosis (n = 50) based on histopathology and clinical evolution determined by consensus in the multidisciplinary committee. All patients underwent dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) with leakage correction and contrast preload, and rCBV was normalised to contralateral white matter. PSR was calculated from the T2* signal-time curve as (S1–Smin)/(S0–Smin). Diagnostic performance was assessed using ROC analysis and the Youden index. Results The median rCBV was significantly higher in tumor progression than in radiation necrosis (4.21 vs. 1.6; p < 0.001), whereas the PSR was significantly lower (59.58% vs. 88.61%, p < 0.001). AUC was 0.86 for rCBV and 0.99 for PSR. PSR outperformed rCBV (p = 0.0028, DeLong test). An optimal cut-off value for rCBV of 2.42 yielded 91.7% sensitivity and 72.2% specificity and for PSR of 68.8% yielded 95.8% sensitivity and 98.1% specificity. Conclusion PSR is more accurate than rCBV in distinguishing tumor progression versus radiation necrosis after SRS in brain metastases. PSR is a reliable, non-invasive biomarker that can improve clinical decision-making.
- 29 October 2025
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 176 (1) , 1-10
Percentage of signal recovery (PSR): a more accurate marker than rCBV for differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiosurgery
Purpose To compare the diagnostic performance of relative cerebral blood volume (rCBV) and percentage of signal recovery (PSR), both derived from dynamic susceptibility contrast (DSC) magnetic resonance imaging (MRI), in distinguishing tumor progression from radiation necrosis in brain metastases that have been treated with stereotactic radiosurgery (SRS). Methods This retrospective, single-centre study analysed 96 brain metastases with post-radiotherapy increase in contrast enhancement. The lesions were classified as tumor progression (n = 46) or radiation necrosis (n = 50) based on histopathology and clinical evolution determined by consensus in the multidisciplinary committee. All patients underwent dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) with leakage correction and contrast preload, and rCBV was normalised to contralateral white matter. PSR was calculated from the T2* signal-time curve as (S1–Smin)/(S0–Smin). Diagnostic performance was assessed using ROC analysis and the Youden index. Results The median rCBV was significantly higher in tumor progression than in radiation necrosis (4.21 vs. 1.6; p < 0.001), whereas the PSR was significantly lower (59.58% vs. 88.61%, p < 0.001). AUC was 0.86 for rCBV and 0.99 for PSR. PSR outperformed rCBV (p = 0.0028, DeLong test). An optimal cut-off value for rCBV of 2.42 yielded 91.7% sensitivity and 72.2% specificity and for PSR of 68.8% yielded 95.8% sensitivity and 98.1% specificity. Conclusion PSR is more accurate than rCBV in distinguishing tumor progression versus radiation necrosis after SRS in brain metastases. PSR is a reliable, non-invasive biomarker that can improve clinical decision-making.
- Open Access
- 15 September 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Improved target volume delineation for stereotactic radiosurgery in brain metastases using post-contrast 3D T1 TSE black-blood MRI
Background: Accurate delineation of brain metastases is essential for the success of stereotactic radiosurgery (SRS). This study aimed to compare the morphological and volumetric characteristics of brain metastases using post-contrast 3D T1 gradient-recalled echo (GRE) and 3D T1 black-blood turbo-spin-echo (TSE) sequences. The hypothesis was that gross tumor volumes (GTV) and planning target volumes (PTVs) would be larger on black-blood sequences. Methods: A retrospective review was conducted on 74 adult patients with untreated brain metastases who underwent MRI during a 12-month period. Post-contrast 3D T1 GRE and black-blood TSE sequences were acquired using a 1.5 T MRI. A total of 167 brain metastases were delineated separately by a neuroradiologist and a radiation oncologist, who then determined the consensus GTV and PTV (2 mm). The volumes were then statistically compared using Wilcoxon matched-pairs tests. Results: The inter-observer agreement (DICE index) was higher for black-blood sequences (0.84) than for GRE sequences (0.76). The mean GTV increased significantly from 1.84 cc on GRE sequences to 2.16 cc on black-blood sequences (a 29.8% increase, P < .001). Similarly, the mean PTV increased from 3.30 to 3.77 cc (a 32.5% increase; P < .001). Black-blood sequences depicted larger volumes in 80% of metastases, showing superior visualization of lesion margins and reduced artifacts (P < .001). Conclusion: Post-contrast black-blood sequences produce a significantly larger GTV and PTV than GRE, thereby improving target delineation for SRS. These findings suggest that black-blood MRI should be incorporated into routine planning to optimize treatment accuracy.
- 15 September 2025
- Published by Oxford University Press (OUP) in Neuro-Oncology Advances
- Vol. 8 (1)
Open AccessImproved target volume delineation for stereotactic radiosurgery in brain metastases using post-contrast 3D T1 TSE black-blood MRI
Background: Accurate delineation of brain metastases is essential for the success of stereotactic radiosurgery (SRS). This study aimed to compare the morphological and volumetric characteristics of brain metastases using post-contrast 3D T1 gradient-recalled echo (GRE) and 3D T1 black-blood turbo-spin-echo (TSE) sequences. The hypothesis was that gross tumor volumes (GTV) and planning target volumes (PTVs) would be larger on black-blood sequences. Methods: A retrospective review was conducted on 74 adult patients with untreated brain metastases who underwent MRI during a 12-month period. Post-contrast 3D T1 GRE and black-blood TSE sequences were acquired using a 1.5 T MRI. A total of 167 brain metastases were delineated separately by a neuroradiologist and a radiation oncologist, who then determined the consensus GTV and PTV (2 mm). The volumes were then statistically compared using Wilcoxon matched-pairs tests. Results: The inter-observer agreement (DICE index) was higher for black-blood sequences (0.84) than for GRE sequences (0.76). The mean GTV increased significantly from 1.84 cc on GRE sequences to 2.16 cc on black-blood sequences (a 29.8% increase, P < .001). Similarly, the mean PTV increased from 3.30 to 3.77 cc (a 32.5% increase; P < .001). Black-blood sequences depicted larger volumes in 80% of metastases, showing superior visualization of lesion margins and reduced artifacts (P < .001). Conclusion: Post-contrast black-blood sequences produce a significantly larger GTV and PTV than GRE, thereby improving target delineation for SRS. These findings suggest that black-blood MRI should be incorporated into routine planning to optimize treatment accuracy.
- 22 January 2025
- Published by Springer Nature in European Radiology
- Vol. 35 (7) , 4267-4276
Improved detection of brain metastases using contrast-enhanced 3D black-blood TSE sequences compared to post-contrast 3D T1 GRE: a comparative study on 1.5-T MRI
Objectives Brain metastases are the most common intracranial malignancy in adults, and their detection is crucial for treatment planning. Post-contrast 3D T1 gradient-recalled echo (GRE) sequences are commonly used for this purpose, but contrast-enhanced 3D T1 turbo spin-echo (TSE) sequences with motion-sensitized driven-equilibrium (MSDE) technique (“black blood”) may offer improved detection. This study aimed to compare the effectiveness of contrast-enhanced 3D black blood sequences to standard 3D T1 GRE sequences in detecting brain metastases on a 1.5-T MRI. Materials and methods A retrospective analysis of 183 patients with suspected or follow-up brain metastases between May 2022 and September 2023 was conducted. Among these patients, 107 were included in the final analysis. Both post-contrast 3D T1 GRE and 3D black blood sequences were acquired on the same scanner with similar acquisition times. Two neuroradiologists independently evaluated the images for the number, size, and location of metastases. Interobserver variability and statistical analysis were performed. Results Among the 107 patients (mean age 60.8 years ± 13.2 years; 55 males, 52 females), 3D black blood sequences detected a significantly higher number of brain metastases, particularly small lesions (< 5 mm), compared to 3D T1 GRE sequences (p < 0.05). There was no significant difference in detecting large metastases (≥ 5 mm) between the sequences. In addition, the black blood sequences provided better conspicuity of metastases in the majority of patients (85%). Conclusion Contrast-enhanced 3D T1 TSE with MSDE (“black blood”) sequences offer improved detection of brain metastases, especially small lesions, on 1.5-T MRI compared to standard 3D T1 GRE sequences. Key Points Question Accurate identification of the number and location of brain metastases using MRI is essential for planning and managing effective treatment. Findings Contrast-enhanced 3D T1 TSE black blood sequences detected significantly more small brain metastases than standard 3D T1 GRE sequences on 1.5-T MRI. Clinical relevance The use of 3D black blood sequences on 1.5-T MRI may have the potential to improve the accuracy of detection of brain metastases, leading to better treatment planning and potentially improved patient outcomes. Graphical Abstract
- 22 January 2025
- Published by Springer Nature in European Radiology
- Vol. 35 (7) , 4267-4276
Improved detection of brain metastases using contrast-enhanced 3D black-blood TSE sequences compared to post-contrast 3D T1 GRE: a comparative study on 1.5-T MRI
Objectives Brain metastases are the most common intracranial malignancy in adults, and their detection is crucial for treatment planning. Post-contrast 3D T1 gradient-recalled echo (GRE) sequences are commonly used for this purpose, but contrast-enhanced 3D T1 turbo spin-echo (TSE) sequences with motion-sensitized driven-equilibrium (MSDE) technique (“black blood”) may offer improved detection. This study aimed to compare the effectiveness of contrast-enhanced 3D black blood sequences to standard 3D T1 GRE sequences in detecting brain metastases on a 1.5-T MRI. Materials and methods A retrospective analysis of 183 patients with suspected or follow-up brain metastases between May 2022 and September 2023 was conducted. Among these patients, 107 were included in the final analysis. Both post-contrast 3D T1 GRE and 3D black blood sequences were acquired on the same scanner with similar acquisition times. Two neuroradiologists independently evaluated the images for the number, size, and location of metastases. Interobserver variability and statistical analysis were performed. Results Among the 107 patients (mean age 60.8 years ± 13.2 years; 55 males, 52 females), 3D black blood sequences detected a significantly higher number of brain metastases, particularly small lesions (< 5 mm), compared to 3D T1 GRE sequences (p < 0.05). There was no significant difference in detecting large metastases (≥ 5 mm) between the sequences. In addition, the black blood sequences provided better conspicuity of metastases in the majority of patients (85%). Conclusion Contrast-enhanced 3D T1 TSE with MSDE (“black blood”) sequences offer improved detection of brain metastases, especially small lesions, on 1.5-T MRI compared to standard 3D T1 GRE sequences. Key Points Question Accurate identification of the number and location of brain metastases using MRI is essential for planning and managing effective treatment. Findings Contrast-enhanced 3D T1 TSE black blood sequences detected significantly more small brain metastases than standard 3D T1 GRE sequences on 1.5-T MRI. Clinical relevance The use of 3D black blood sequences on 1.5-T MRI may have the potential to improve the accuracy of detection of brain metastases, leading to better treatment planning and potentially improved patient outcomes. Graphical Abstract
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (1) , e240123
Top 10 Most-feared Diagnostic Errors for Radiology Trainees in Pediatric Neuroradiology Emergencies
Recognition of imaging findings of the most-feared pediatric neuroradiology diagnostic errors for on-call trainees will aid in the identification and prevention of such errors.
- 1 January 2025
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 45 (1) , e240123
Top 10 Most-feared Diagnostic Errors for Radiology Trainees in Pediatric Neuroradiology Emergencies
Recognition of imaging findings of the most-feared pediatric neuroradiology diagnostic errors for on-call trainees will aid in the identification and prevention of such errors.